72 related articles for article (PubMed ID: 20513026)
1. XRP6258-induced gene expression patterns in head and neck cancer carcinoma.
Yoo GH; Kafri Z; Ensley JF; Lonardo F; Kim H; Folbe AJ; Won J; Stevens T; Lin HS
Laryngoscope; 2010 Jun; 120(6):1114-9. PubMed ID: 20513026
[TBL] [Abstract][Full Text] [Related]
2. BMS-275183-induced gene expression patterns in head and neck carcinoma.
Yoo GH; Tran VR; Lemonnier LA; Ezzat WH; Subramanian G; Piechocki MP; Ensley JF; Lonardo F; Kim H; Lin HS
Am J Otolaryngol; 2007; 28(5):309-15. PubMed ID: 17826531
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot.
Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA
Clin Cancer Res; 2002 Dec; 8(12):3910-21. PubMed ID: 12473607
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
[TBL] [Abstract][Full Text] [Related]
5. An in vivo evaluation of docetaxel delivered intratumorally in head and neck squamous cell carcinoma.
Yoo GH; Subramanian G; Boinpally RR; Iskander A; Shehadeh N; Oliver J; Ezzat W; Piechocki MP; Ensley JF; Lin HS; Shibuya TY; Polin L; Parchment RE
Arch Otolaryngol Head Neck Surg; 2005 May; 131(5):418-29. PubMed ID: 15897421
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer.
Yoo GH; Piechocki MP; Oliver J; Lonardo F; Zumstein L; Lin HS; Kim H; Shibuya TY; Shehadeh N; Ensley JF
Laryngoscope; 2004 Nov; 114(11):1871-9. PubMed ID: 15510008
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic alteration of VEGF, PDGF and PDGFRα/β expression under 5-FU vs. docetaxel in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Aderhold C; Umbreit C; Faber A; Sauter A; Sommer JU; Birk R; Erben P; Hofheinz RD; Stern-Straeter J; Hörmann K; Schultz JD
Anticancer Res; 2013 May; 33(5):1951-61. PubMed ID: 23645743
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
Kothari V; Mulherkar R
Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
[TBL] [Abstract][Full Text] [Related]
10. Effect of docetaxel on the surgical tumor microenvironment of head and neck cancer in murine models.
Yoo GH; Subramanian G; Piechocki MP; Ensley JF; Kucuk O; Tulunay OE; Lonardo F; Kim H; Won J; Stevens T; Lin HS
Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):735-42. PubMed ID: 18645124
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.
Saigal B; Glisson BS; Johnson FM
Anticancer Drugs; 2008 Jun; 19(5):465-75. PubMed ID: 18418213
[TBL] [Abstract][Full Text] [Related]
12. Molecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosis.
Hernández-Vargas H; Palacios J; Moreno-Bueno G
Oncogene; 2007 May; 26(20):2902-13. PubMed ID: 17099726
[TBL] [Abstract][Full Text] [Related]
13. mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
Schedel F; Pries R; Thode B; Wollmann B; Wulff S; Jocham D; Wollenberg B; Kausch I
Oncol Rep; 2011 Mar; 25(3):763-8. PubMed ID: 21240463
[TBL] [Abstract][Full Text] [Related]
14. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
15. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
16. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
17. p53 apoptotic response to DNA damage dependent on bcl2 but not bax in head and neck squamous cell carcinoma lines.
Crowe DL; Sinha UK
Head Neck; 2006 Jan; 28(1):15-23. PubMed ID: 16302195
[TBL] [Abstract][Full Text] [Related]
18. Unexpected alteration of β-catenin and c-KIT expression by 5-FU and docetaxel in p16-positive squamous cell carcinoma compared to HPV-negative HNSCC cells in vitro.
Umbreit C; Aderhold C; Faber A; Sommer JU; Sauter A; Hofheinz RD; Stern-Sträter J; Hoermann K; Schultz JD
Anticancer Res; 2013 Jun; 33(6):2457-65. PubMed ID: 23749896
[TBL] [Abstract][Full Text] [Related]
19. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
[TBL] [Abstract][Full Text] [Related]
20. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]